These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 35152416)

  • 61. A double-blind randomized comparison of nortriptyline plus perphenazine versus nortriptyline plus placebo in the treatment of psychotic depression in late life.
    Mulsant BH; Sweet RA; Rosen J; Pollock BG; Zubenko GS; Flynn T; Begley AE; Mazumdar S; Reynolds CF
    J Clin Psychiatry; 2001 Aug; 62(8):597-604. PubMed ID: 11561930
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Does lithium prevent relapse following successful electroconvulsive therapy for major depression? A systematic review and meta-analysis.
    Lambrichts S; Detraux J; Vansteelandt K; Nordenskjöld A; Obbels J; Schrijvers D; Sienaert P
    Acta Psychiatr Scand; 2021 Apr; 143(4):294-306. PubMed ID: 33506961
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effects of a Course of Right Unilateral Ultrabrief Pulse Electroconvulsive Therapy Combined With Venlafaxine on Insomnia Symptoms in Elderly Depressed Patients.
    McCall WV; Lisanby SH; Rosenquist PB; Dooley M; Husain MM; Knapp RG; Petrides G; Rudorfer MV; Young RC; McClintock SM; Mueller M; Prudic J; Greenberg RM; Weiner RD; Bailine SH; Riley MA; McCloud L; Kellner CH;
    J Clin Psychiatry; 2018; 79(2):. PubMed ID: 28742292
    [TBL] [Abstract][Full Text] [Related]  

  • 64. One-year follow-up after discontinuing maintenance electroconvulsive therapy.
    Huuhka K; Viikki M; Tammentie T; Tuohimaa K; Björkqvist M; Alanen HM; Leinonen E; Kampman O
    J ECT; 2012 Dec; 28(4):225-8. PubMed ID: 22531209
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Determinants of relapse after electroconvulsive therapy in depressed patients].
    Grüter J; Grözinger M
    Fortschr Neurol Psychiatr; 2018 Nov; 86(11):711-717. PubMed ID: 30654400
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Does the addition of pindolol accelerate the response to electroconvulsive therapy in patients with major depression? A double-blind, placebo-controlled pilot study.
    Shiah IS; Yatham LN; Srisurapanont M; Lam RW; Tam EM; Zis AP
    J Clin Psychopharmacol; 2000 Jun; 20(3):373-8. PubMed ID: 10831027
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Concomitant Transcranial Direct Current Stimulation With Ultrabrief Electroconvulsive Therapy: A 2-Week Double-Blind Randomized Sham-Controlled Trial.
    Mayur P; Howari R; Byth K; Vannitamby R
    J ECT; 2018 Dec; 34(4):291-295. PubMed ID: 29369074
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Antidepressant medication treatment failure does not predict lower remission with ECT for major depressive disorder: a report from the consortium for research in electroconvulsive therapy.
    Rasmussen KG; Mueller M; Knapp RG; Husain MM; Rummans TA; Sampson SM; O'Connor MK; Petrides G; Fink M; Kellner CH
    J Clin Psychiatry; 2007 Nov; 68(11):1701-6. PubMed ID: 18052563
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A randomized, controlled trial with 6-month follow-up of repetitive transcranial magnetic stimulation and electroconvulsive therapy for severe depression.
    Eranti S; Mogg A; Pluck G; Landau S; Purvis R; Brown RG; Howard R; Knapp M; Philpot M; Rabe-Hesketh S; Romeo R; Rothwell J; Edwards D; McLoughlin DM
    Am J Psychiatry; 2007 Jan; 164(1):73-81. PubMed ID: 17202547
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Treatment failure with a tricyclic antidepressant followed by lithium addition and response to subsequent electroconvulsive therapy.
    Heijnen WT; van den Broek WW; Birkenhäger TK
    J Clin Psychiatry; 2008 Dec; 69(12):1887-91. PubMed ID: 19014754
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Propofol and methohexital as anesthetic agents for electroconvulsive therapy: a randomized, double-blind comparison of electroconvulsive therapy seizure quality, therapeutic efficacy, and cognitive performance.
    Geretsegger C; Nickel M; Judendorfer B; Rochowanski E; Novak E; Aichhorn W
    J ECT; 2007 Dec; 23(4):239-43. PubMed ID: 18090696
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Which residual symptoms predict relapse after successful electroconvulsive therapy for late-life depression?
    Lambrichts S; Vansteelandt K; Hebbrecht K; Wagenmakers MJ; Oudega ML; Obbels J; van Exel E; Dols A; Bouckaert F; Schrijvers D; Verwijk E; Sienaert P
    J Psychiatr Res; 2022 Oct; 154():111-116. PubMed ID: 35933854
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Three and six-month outcome following courses of either ECT or rTMS in a population of severely depressed individuals--preliminary report.
    Dannon PN; Dolberg OT; Schreiber S; Grunhaus L
    Biol Psychiatry; 2002 Apr; 51(8):687-90. PubMed ID: 11955470
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Confirmatory Efficacy and Safety Trial of Magnetic Seizure Therapy for Depression (CREST-MST): study protocol for a randomized non-inferiority trial of magnetic seizure therapy versus electroconvulsive therapy.
    Daskalakis ZJ; Tamminga C; Throop A; Palmer L; Dimitrova J; Farzan F; Thorpe KE; McClintock SM; Blumberger DM
    Trials; 2021 Nov; 22(1):786. PubMed ID: 34749782
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Continuation treatment of delusional depression in older adults.
    Meyers BS; Klimstra SA; Gabriele M; Hamilton M; Kakuma T; Tirumalasetti F; Alexopoulos GS
    Am J Geriatr Psychiatry; 2001; 9(4):415-22. PubMed ID: 11739068
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Depression severity in electroconvulsive therapy (ECT) versus pharmacotherapy trials.
    Kellner CH; Kaicher DC; Banerjee H; Knapp RG; Shapiro RJ; Briggs MC; Pasculli RM; Popeo DM; Ahle GM; Liebman LS
    J ECT; 2015 Mar; 31(1):31-3. PubMed ID: 24839981
    [TBL] [Abstract][Full Text] [Related]  

  • 77. One-year follow-up after successful ECT: a naturalistic study in depressed inpatients.
    Birkenhäger TK; Renes JW; Pluijms EM
    J Clin Psychiatry; 2004 Jan; 65(1):87-91. PubMed ID: 14744175
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Ketamine Versus Midazolam for Depression Relapse Prevention Following Successful Electroconvulsive Therapy: A Randomized Controlled Pilot Trial.
    Finnegan M; Galligan T; Ryan K; Shanahan E; Harkin A; Daly L; McLoughlin DM
    J ECT; 2019 Jun; 35(2):115-121. PubMed ID: 30531397
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A naturalistic study of high-dose unilateral ECT among severely depressed inpatients: how does it work in the clinical practice?
    Alves LP; Freire TF; Fleck MP; Rocha NS
    BMC Psychiatry; 2016 Nov; 16(1):396. PubMed ID: 27836011
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Depression: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2016; 16(5):1-66. PubMed ID: 27099642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.